These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11439343)

  • 1. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias.
    Hemenway CS; de Erkenez AC; Gould GC
    Oncogene; 2001 Jun; 20(29):3798-805. PubMed ID: 11439343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.
    García-Cuéllar MP; Zilles O; Schreiner SA; Birke M; Winkler TH; Slany RK
    Oncogene; 2001 Jan; 20(4):411-9. PubMed ID: 11313972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
    García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
    Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
    Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
    Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.
    Satijn DP; Otte AP
    Mol Cell Biol; 1999 Jan; 19(1):57-68. PubMed ID: 9858531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
    Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
    Srinivasan RS; de Erkenez AC; Hemenway CS
    Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL fusion partners AF4 and AF9 interact at subnuclear foci.
    Erfurth F; Hemenway CS; de Erkenez AC; Domer PH
    Leukemia; 2004 Jan; 18(1):92-102. PubMed ID: 14603337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
    Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M
    Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and analysis of a third mouse Polycomb gene, MPc3.
    Hemenway CS; Halligan BW; Gould GC; Levy LS
    Gene; 2000 Jan; 242(1-2):31-40. PubMed ID: 10721694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis.
    Sano K
    Leuk Lymphoma; 2001 Aug; 42(4):595-602. PubMed ID: 11697487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. t(11;14)(q23;q24) generates an MLL-human gephyrin fusion gene along with a de facto truncated MLL in acute monoblastic leukemia.
    Kuwada N; Kimura F; Matsumura T; Yamashita T; Nakamura Y; Wakimoto N; Ikeda T; Sato K; Motoyoshi K
    Cancer Res; 2001 Mar; 61(6):2665-9. PubMed ID: 11289145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis.
    Dobson CL; Warren AJ; Pannell R; Forster A; Lavenir I; Corral J; Smith AJ; Rabbitts TH
    EMBO J; 1999 Jul; 18(13):3564-74. PubMed ID: 10393173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.
    Collins EC; Appert A; Ariza-McNaughton L; Pannell R; Yamada Y; Rabbitts TH
    Mol Cell Biol; 2002 Oct; 22(20):7313-24. PubMed ID: 12242306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
    Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.
    Ma C; Staudt LM
    Blood; 1996 Jan; 87(2):734-45. PubMed ID: 8555498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.
    Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL
    Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.